Q1 2023 Holdings
Filed 2023-05-15 | 75 holdings | $330.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $4 | 66,666 | 0.0% |
| Nuvation Bio Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $32 | 266,666 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $403 | 347,300 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $655 | 209,227 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $667 | 2,913,091 | 0.0% |
| Alaunos Therapeutics Inc | COM | 98973P101 | $945 | 1,500,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.6K | 2,250,000 | 0.0% |
| BioAtla Inc(BCAB) | COM | 09077B104 | $1.8K | 686,347 | 0.0% |
| EQRx Inc | COM | 26886C107 | $1.9K | 1,000,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $2.0K | 500,000 | 0.0% |
| Third Harmonic Bio Inc(THRD) | COM | 88427A107 | $2.4K | 570,417 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $2.5K | 1,450,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $2.5K | 2,202,333 | 0.0% |
| Milestone Pharmaceuticals In(MIST) | COM | 59935V107 | $2.8K | 698,861 | 0.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $2.8K | 130,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $2.9K | 500,000 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $3.1K | 350,000 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $3.2K | 510,000 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $4.0K | 699,047 | 0.0% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $4.2K | 3,336,928 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $4.6K | 3,284,072 | 0.0% |
| 2Seventy Bio Inc(TSVT*) | COMMON STOCK | 901384107 | $4.7K | 459,836 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.8K | 1,251,137 | 0.0% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $4.9K | 250,000 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $5.1K | 500,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $5.5K | 300,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $6.0K | 1,054,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $7.5K | 200,000 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $10.9K | 1,224,892 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $13.0K | 1,650,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $14.5K | 300,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $15.1K | 3,163,795 | 0.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $15.6K | 710,644 | 0.0% |
| Day One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $15.9K | 1,189,943 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $17.2K | 1,121,327 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $18.2K | 2,500,000 | 0.0% |
| Rain Oncology Inc | COM | 75082Q105 | $18.8K | 2,147,212 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | COM | 46583P102 | $20.1K | 825,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $21.5K | 600,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $22.3K | 1,150,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $22.6K | 3,705,133 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $23.0K | 3,200,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $25.1K | 1,466,051 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $25.8K | 2,325,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $28.1K | 7,123,642 | 0.0% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $28.3K | 1,300,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $28.5K | 850,000 | 0.0% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $29.3K | 2,154,058 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $30.2K | 2,202,812 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $31.6K | 1,210,192 | 0.0% |